GO:0005488 | binding | 60.0% (150/250) | 0.92 | 0.0 | 0.0 |
GO:0005515 | protein binding | 30.4% (76/250) | 1.43 | 0.0 | 0.0 |
GO:0032559 | adenyl ribonucleotide binding | 19.6% (49/250) | 1.43 | 0.0 | 0.0 |
GO:0003674 | molecular_function | 70.8% (177/250) | 0.44 | 0.0 | 0.0 |
GO:0032555 | purine ribonucleotide binding | 20.4% (51/250) | 1.33 | 0.0 | 0.0 |
GO:0030554 | adenyl nucleotide binding | 19.6% (49/250) | 1.34 | 0.0 | 0.0 |
GO:0032553 | ribonucleotide binding | 20.4% (51/250) | 1.32 | 0.0 | 0.0 |
GO:0097367 | carbohydrate derivative binding | 20.4% (51/250) | 1.31 | 0.0 | 0.0 |
GO:0017076 | purine nucleotide binding | 20.4% (51/250) | 1.26 | 0.0 | 0.0 |
GO:1901265 | nucleoside phosphate binding | 20.8% (52/250) | 1.21 | 0.0 | 1e-06 |
GO:0000166 | nucleotide binding | 20.8% (52/250) | 1.21 | 0.0 | 1e-06 |
GO:0097159 | organic cyclic compound binding | 34.0% (85/250) | 0.84 | 0.0 | 1e-06 |
GO:0005524 | ATP binding | 17.2% (43/250) | 1.31 | 0.0 | 2e-06 |
GO:0043168 | anion binding | 20.4% (51/250) | 1.17 | 0.0 | 2e-06 |
GO:1901363 | heterocyclic compound binding | 20.8% (52/250) | 1.15 | 0.0 | 2e-06 |
GO:0036094 | small molecule binding | 20.8% (52/250) | 1.13 | 0.0 | 2e-06 |
GO:0043167 | ion binding | 26.4% (66/250) | 0.94 | 0.0 | 4e-06 |
GO:0035639 | purine ribonucleoside triphosphate binding | 18.0% (45/250) | 1.22 | 0.0 | 4e-06 |
GO:0016570 | histone modification | 2.8% (7/250) | 3.84 | 1e-06 | 2.3e-05 |
GO:0018205 | peptidyl-lysine modification | 2.4% (6/250) | 4.27 | 1e-06 | 2.4e-05 |
GO:0003714 | transcription corepressor activity | 2.0% (5/250) | 4.82 | 1e-06 | 2.8e-05 |
GO:0016071 | mRNA metabolic process | 4.0% (10/250) | 2.91 | 1e-06 | 3.4e-05 |
GO:0018193 | peptidyl-amino acid modification | 3.2% (8/250) | 3.32 | 2e-06 | 4.9e-05 |
GO:0006397 | mRNA processing | 3.6% (9/250) | 3.05 | 2e-06 | 4.9e-05 |
GO:0140657 | ATP-dependent activity | 7.6% (19/250) | 1.76 | 4e-06 | 0.000121 |
GO:0008278 | cohesin complex | 1.2% (3/250) | 6.08 | 9e-06 | 0.000232 |
GO:0008150 | biological_process | 50.4% (126/250) | 0.44 | 1.1e-05 | 0.000295 |
GO:0034968 | histone lysine methylation | 1.6% (4/250) | 4.78 | 1.3e-05 | 0.000305 |
GO:0016571 | histone methylation | 1.6% (4/250) | 4.78 | 1.3e-05 | 0.000305 |
GO:0140658 | ATP-dependent chromatin remodeler activity | 2.0% (5/250) | 4.04 | 1.3e-05 | 0.000312 |
GO:0043687 | post-translational protein modification | 4.4% (11/250) | 2.32 | 1.6e-05 | 0.000353 |
GO:0018022 | peptidyl-lysine methylation | 1.6% (4/250) | 4.55 | 2.5e-05 | 0.00052 |
GO:0007062 | sister chromatid cohesion | 1.6% (4/250) | 4.55 | 2.5e-05 | 0.00052 |
GO:0043401 | steroid hormone mediated signaling pathway | 1.6% (4/250) | 4.5 | 2.8e-05 | 0.000569 |
GO:0009742 | brassinosteroid mediated signaling pathway | 1.6% (4/250) | 4.5 | 2.8e-05 | 0.000569 |
GO:0031324 | negative regulation of cellular metabolic process | 3.2% (8/250) | 2.72 | 3.3e-05 | 0.00065 |
GO:0008092 | cytoskeletal protein binding | 4.0% (10/250) | 2.31 | 4.1e-05 | 0.000697 |
GO:0140938 | histone H3 methyltransferase activity | 0.8% (2/250) | 7.3 | 4e-05 | 0.000698 |
GO:0042054 | histone methyltransferase activity | 0.8% (2/250) | 7.3 | 4e-05 | 0.000698 |
GO:0010605 | negative regulation of macromolecule metabolic process | 3.2% (8/250) | 2.69 | 3.9e-05 | 0.000713 |
GO:0009892 | negative regulation of metabolic process | 3.2% (8/250) | 2.69 | 3.9e-05 | 0.000713 |
GO:0051253 | negative regulation of RNA metabolic process | 2.0% (5/250) | 3.54 | 7.3e-05 | 0.001225 |
GO:0045934 | negative regulation of nucleobase-containing compound metabolic process | 2.0% (5/250) | 3.5 | 8.4e-05 | 0.001375 |
GO:0030120 | vesicle coat | 1.6% (4/250) | 4.09 | 8.8e-05 | 0.001397 |
GO:0016885 | ligase activity, forming carbon-carbon bonds | 0.8% (2/250) | 6.72 | 0.000119 | 0.001738 |
GO:0016421 | CoA carboxylase activity | 0.8% (2/250) | 6.72 | 0.000119 | 0.001738 |
GO:0000245 | spliceosomal complex assembly | 0.8% (2/250) | 6.72 | 0.000119 | 0.001738 |
GO:0003989 | acetyl-CoA carboxylase activity | 0.8% (2/250) | 6.72 | 0.000119 | 0.001738 |
GO:0048523 | negative regulation of cellular process | 3.2% (8/250) | 2.44 | 0.000129 | 0.001849 |
GO:0003712 | transcription coregulator activity | 2.0% (5/250) | 3.34 | 0.000141 | 0.001979 |
GO:0003676 | nucleic acid binding | 16.4% (41/250) | 0.86 | 0.000149 | 0.002045 |
GO:0043531 | ADP binding | 2.4% (6/250) | 2.9 | 0.000165 | 0.002224 |
GO:0030117 | membrane coat | 2.0% (5/250) | 3.29 | 0.000169 | 0.002232 |
GO:0031441 | negative regulation of mRNA 3'-end processing | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:0061013 | regulation of mRNA catabolic process | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:0050686 | negative regulation of mRNA processing | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:0043488 | regulation of mRNA stability | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:0070717 | poly-purine tract binding | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:0043487 | regulation of RNA stability | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:1900364 | negative regulation of mRNA polyadenylation | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:1903312 | negative regulation of mRNA metabolic process | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:0031440 | regulation of mRNA 3'-end processing | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:0008143 | poly(A) binding | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:0003727 | single-stranded RNA binding | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:0032051 | clathrin light chain binding | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:0071439 | clathrin complex | 0.8% (2/250) | 6.3 | 0.000237 | 0.002444 |
GO:0140993 | histone modifying activity | 1.6% (4/250) | 3.81 | 0.00019 | 0.002468 |
GO:0048519 | negative regulation of biological process | 3.2% (8/250) | 2.35 | 0.000198 | 0.002521 |
GO:0008213 | protein alkylation | 1.6% (4/250) | 3.69 | 0.000265 | 0.002654 |
GO:0006479 | protein methylation | 1.6% (4/250) | 3.69 | 0.000265 | 0.002654 |
GO:0016459 | myosin complex | 1.2% (3/250) | 4.43 | 0.000353 | 0.00348 |
GO:0050794 | regulation of cellular process | 12.4% (31/250) | 0.94 | 0.000379 | 0.003682 |
GO:0009987 | cellular process | 33.2% (83/250) | 0.49 | 0.000393 | 0.003765 |
GO:0016043 | cellular component organization | 7.2% (18/250) | 1.29 | 0.000488 | 0.004612 |
GO:0004674 | protein serine/threonine kinase activity | 2.4% (6/250) | 2.59 | 0.000516 | 0.004751 |
GO:0071840 | cellular component organization or biogenesis | 7.6% (19/250) | 1.24 | 0.000515 | 0.004807 |
GO:0050684 | regulation of mRNA processing | 0.8% (2/250) | 5.72 | 0.000589 | 0.005215 |
GO:0031329 | regulation of cellular catabolic process | 0.8% (2/250) | 5.72 | 0.000589 | 0.005215 |
GO:1903311 | regulation of mRNA metabolic process | 0.8% (2/250) | 5.72 | 0.000589 | 0.005215 |
GO:0009755 | hormone-mediated signaling pathway | 2.4% (6/250) | 2.52 | 0.00067 | 0.00586 |
GO:0090304 | nucleic acid metabolic process | 9.2% (23/250) | 1.07 | 0.000692 | 0.005981 |
GO:0065007 | biological regulation | 12.8% (32/250) | 0.87 | 0.000752 | 0.006416 |
GO:0048507 | meristem development | 0.8% (2/250) | 5.5 | 0.000821 | 0.006527 |
GO:0003724 | RNA helicase activity | 1.6% (4/250) | 3.28 | 0.000784 | 0.00653 |
GO:0008186 | ATP-dependent activity, acting on RNA | 1.6% (4/250) | 3.28 | 0.000784 | 0.00653 |
GO:0003774 | cytoskeletal motor activity | 2.0% (5/250) | 2.79 | 0.000818 | 0.006579 |
GO:0051172 | negative regulation of nitrogen compound metabolic process | 2.0% (5/250) | 2.79 | 0.000818 | 0.006579 |
GO:0016070 | RNA metabolic process | 6.4% (16/250) | 1.32 | 0.000815 | 0.00671 |
GO:0031327 | negative regulation of cellular biosynthetic process | 2.4% (6/250) | 2.45 | 0.000883 | 0.006718 |
GO:0010558 | negative regulation of macromolecule biosynthetic process | 2.4% (6/250) | 2.45 | 0.000883 | 0.006718 |
GO:0009890 | negative regulation of biosynthetic process | 2.4% (6/250) | 2.45 | 0.000883 | 0.006718 |
GO:0018024 | obsolete histone lysine N-methyltransferase activity | 1.2% (3/250) | 3.98 | 0.000896 | 0.006747 |
GO:0006952 | defense response | 3.2% (8/250) | 2.01 | 0.000921 | 0.006856 |
GO:0003723 | RNA binding | 6.4% (16/250) | 1.31 | 0.000875 | 0.006886 |
GO:0050789 | regulation of biological process | 12.4% (31/250) | 0.86 | 0.000996 | 0.007186 |
GO:0016887 | ATP hydrolysis activity | 3.6% (9/250) | 1.85 | 0.000989 | 0.007214 |
GO:0045184 | establishment of protein localization | 3.6% (9/250) | 1.85 | 0.000989 | 0.007214 |
GO:0006996 | organelle organization | 4.8% (12/250) | 1.53 | 0.001092 | 0.00728 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 6.0% (15/250) | 1.34 | 0.001022 | 0.007303 |
GO:0010073 | meristem maintenance | 0.8% (2/250) | 5.3 | 0.00109 | 0.007333 |
GO:0003918 | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 0.8% (2/250) | 5.3 | 0.00109 | 0.007333 |
GO:0030132 | clathrin coat of coated pit | 0.8% (2/250) | 5.3 | 0.00109 | 0.007333 |
GO:0030118 | clathrin coat | 0.8% (2/250) | 5.3 | 0.00109 | 0.007333 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 0.8% (2/250) | 5.3 | 0.00109 | 0.007333 |
GO:0030125 | clathrin vesicle coat | 0.8% (2/250) | 5.3 | 0.00109 | 0.007333 |
GO:0008104 | protein localization | 3.6% (9/250) | 1.82 | 0.001177 | 0.007629 |
GO:0070727 | cellular macromolecule localization | 3.6% (9/250) | 1.82 | 0.001177 | 0.007629 |
GO:0033036 | macromolecule localization | 3.6% (9/250) | 1.82 | 0.001177 | 0.007629 |
GO:0022402 | cell cycle process | 2.0% (5/250) | 2.63 | 0.001372 | 0.008812 |
GO:0009738 | abscisic acid-activated signaling pathway | 0.8% (2/250) | 5.13 | 0.001395 | 0.008877 |
GO:0045292 | mRNA cis splicing, via spliceosome | 0.8% (2/250) | 4.98 | 0.001736 | 0.010951 |
GO:0015631 | tubulin binding | 2.4% (6/250) | 2.23 | 0.001891 | 0.011817 |
GO:0008270 | zinc ion binding | 4.4% (11/250) | 1.5 | 0.001977 | 0.012247 |
GO:0016462 | pyrophosphatase activity | 4.8% (12/250) | 1.4 | 0.002256 | 0.013853 |
GO:0005986 | sucrose biosynthetic process | 0.8% (2/250) | 4.72 | 0.002526 | 0.014982 |
GO:0090576 | RNA polymerase III transcription regulator complex | 0.8% (2/250) | 4.72 | 0.002526 | 0.014982 |
GO:0000127 | transcription factor TFIIIC complex | 0.8% (2/250) | 4.72 | 0.002526 | 0.014982 |
GO:0043414 | macromolecule methylation | 1.6% (4/250) | 2.83 | 0.002511 | 0.015284 |
GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | 4.8% (12/250) | 1.37 | 0.00261 | 0.01535 |
GO:0032991 | protein-containing complex | 8.4% (21/250) | 0.97 | 0.002634 | 0.015365 |
GO:0016817 | hydrolase activity, acting on acid anhydrides | 4.8% (12/250) | 1.36 | 0.002818 | 0.016301 |
GO:0051641 | cellular localization | 4.0% (10/250) | 1.5 | 0.003116 | 0.01788 |
GO:0006396 | RNA processing | 3.6% (9/250) | 1.59 | 0.00335 | 0.019064 |
GO:0140326 | ATPase-coupled intramembrane lipid transporter activity | 0.8% (2/250) | 4.5 | 0.003453 | 0.019495 |
GO:0017111 | ribonucleoside triphosphate phosphatase activity | 4.4% (11/250) | 1.39 | 0.00367 | 0.020551 |
GO:0030126 | COPI vesicle coat | 0.8% (2/250) | 4.4 | 0.003968 | 0.021367 |
GO:0016278 | lysine N-methyltransferase activity | 0.8% (2/250) | 4.4 | 0.003968 | 0.021367 |
GO:0006384 | transcription initiation at RNA polymerase III promoter | 0.8% (2/250) | 4.4 | 0.003968 | 0.021367 |
GO:0016279 | protein-lysine N-methyltransferase activity | 0.8% (2/250) | 4.4 | 0.003968 | 0.021367 |
GO:0007165 | signal transduction | 3.6% (9/250) | 1.55 | 0.003944 | 0.02191 |
GO:0004721 | phosphoprotein phosphatase activity | 1.6% (4/250) | 2.62 | 0.004245 | 0.022512 |
GO:0071702 | organic substance transport | 4.0% (10/250) | 1.44 | 0.004236 | 0.022634 |
GO:0032784 | regulation of DNA-templated transcription elongation | 0.8% (2/250) | 4.3 | 0.004516 | 0.022908 |
GO:0006475 | internal protein amino acid acetylation | 0.8% (2/250) | 4.3 | 0.004516 | 0.022908 |
GO:0016573 | histone acetylation | 0.8% (2/250) | 4.3 | 0.004516 | 0.022908 |
GO:0018393 | internal peptidyl-lysine acetylation | 0.8% (2/250) | 4.3 | 0.004516 | 0.022908 |
GO:0018394 | peptidyl-lysine acetylation | 0.8% (2/250) | 4.3 | 0.004516 | 0.022908 |
GO:0005694 | chromosome | 0.8% (2/250) | 4.3 | 0.004516 | 0.022908 |
GO:0003779 | actin binding | 1.6% (4/250) | 2.56 | 0.004859 | 0.024469 |
GO:0006139 | nucleobase-containing compound metabolic process | 9.6% (24/250) | 0.83 | 0.004959 | 0.024797 |
GO:0140303 | intramembrane lipid transporter activity | 0.8% (2/250) | 4.22 | 0.005097 | 0.025304 |
GO:0006886 | intracellular protein transport | 2.4% (6/250) | 1.93 | 0.005172 | 0.025494 |
GO:0015914 | phospholipid transport | 0.8% (2/250) | 4.13 | 0.00571 | 0.027952 |
GO:0006265 | DNA topological change | 0.8% (2/250) | 4.06 | 0.006356 | 0.028889 |
GO:0043419 | urea catabolic process | 0.4% (1/250) | 7.3 | 0.006329 | 0.028958 |
GO:0009039 | urease activity | 0.4% (1/250) | 7.3 | 0.006329 | 0.028958 |
GO:0035550 | urease complex | 0.4% (1/250) | 7.3 | 0.006329 | 0.028958 |
GO:0019627 | urea metabolic process | 0.4% (1/250) | 7.3 | 0.006329 | 0.028958 |
GO:0004198 | calcium-dependent cysteine-type endopeptidase activity | 0.4% (1/250) | 7.3 | 0.006329 | 0.028958 |
GO:0060147 | regulation of post-transcriptional gene silencing | 0.4% (1/250) | 7.3 | 0.006329 | 0.028958 |
GO:0046975 | histone H3K36 methyltransferase activity | 0.4% (1/250) | 7.3 | 0.006329 | 0.028958 |
GO:0005637 | nuclear inner membrane | 0.4% (1/250) | 7.3 | 0.006329 | 0.028958 |
GO:0010452 | histone H3-K36 methylation | 0.4% (1/250) | 7.3 | 0.006329 | 0.028958 |
GO:0042800 | histone H3K4 methyltransferase activity | 0.4% (1/250) | 7.3 | 0.006329 | 0.028958 |
GO:0032259 | methylation | 1.6% (4/250) | 2.45 | 0.006451 | 0.029136 |
GO:0008017 | microtubule binding | 2.0% (5/250) | 2.09 | 0.006791 | 0.030472 |
GO:0004402 | histone acetyltransferase activity | 0.8% (2/250) | 3.98 | 0.007032 | 0.030767 |
GO:0061733 | peptide-lysine-N-acetyltransferase activity | 0.8% (2/250) | 3.98 | 0.007032 | 0.030767 |
GO:0003916 | DNA topoisomerase activity | 0.8% (2/250) | 3.98 | 0.007032 | 0.030767 |
GO:0015031 | protein transport | 2.8% (7/250) | 1.67 | 0.007012 | 0.031266 |
GO:0006473 | protein acetylation | 0.8% (2/250) | 3.91 | 0.00774 | 0.033654 |
GO:0045892 | negative regulation of DNA-templated transcription | 1.2% (3/250) | 2.89 | 0.007857 | 0.03374 |
GO:1902679 | negative regulation of RNA biosynthetic process | 1.2% (3/250) | 2.89 | 0.007857 | 0.03374 |
GO:0046872 | metal ion binding | 8.8% (22/250) | 0.8 | 0.008578 | 0.03639 |
GO:0003729 | mRNA binding | 1.2% (3/250) | 2.84 | 0.00855 | 0.036493 |
GO:0009894 | regulation of catabolic process | 0.8% (2/250) | 3.78 | 0.009248 | 0.038998 |
GO:0071705 | nitrogen compound transport | 3.2% (8/250) | 1.43 | 0.010615 | 0.044495 |
GO:0019866 | organelle inner membrane | 0.8% (2/250) | 3.66 | 0.010876 | 0.04452 |
GO:0034212 | peptide N-acetyltransferase activity | 0.8% (2/250) | 3.66 | 0.010876 | 0.04452 |
GO:0005319 | lipid transporter activity | 0.8% (2/250) | 3.66 | 0.010876 | 0.04452 |
GO:0043543 | protein acylation | 0.8% (2/250) | 3.66 | 0.010876 | 0.04452 |
GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity | 0.8% (2/250) | 3.6 | 0.011733 | 0.047203 |
GO:0000226 | microtubule cytoskeleton organization | 1.2% (3/250) | 2.68 | 0.011673 | 0.047234 |
GO:0140097 | catalytic activity, acting on DNA | 3.2% (8/250) | 1.4 | 0.011657 | 0.047443 |
GO:0032386 | regulation of intracellular transport | 0.4% (1/250) | 6.3 | 0.012619 | 0.047747 |
GO:0043605 | amide catabolic process | 0.4% (1/250) | 6.3 | 0.012619 | 0.047747 |
GO:2000641 | regulation of early endosome to late endosome transport | 0.4% (1/250) | 6.3 | 0.012619 | 0.047747 |
GO:0071941 | nitrogen cycle metabolic process | 0.4% (1/250) | 6.3 | 0.012619 | 0.047747 |
GO:0016442 | RISC complex | 0.4% (1/250) | 6.3 | 0.012619 | 0.047747 |
GO:0031332 | RNAi effector complex | 0.4% (1/250) | 6.3 | 0.012619 | 0.047747 |
GO:0016035 | zeta DNA polymerase complex | 0.4% (1/250) | 6.3 | 0.012619 | 0.047747 |
GO:0060341 | regulation of cellular localization | 0.4% (1/250) | 6.3 | 0.012619 | 0.047747 |
GO:0005575 | cellular_component | 17.2% (43/250) | 0.5 | 0.01204 | 0.047888 |
GO:0007017 | microtubule-based process | 2.0% (5/250) | 1.88 | 0.011975 | 0.0479 |
GO:0043169 | cation binding | 8.8% (22/250) | 0.74 | 0.013005 | 0.048943 |
GO:0046483 | heterocycle metabolic process | 9.6% (24/250) | 0.7 | 0.013121 | 0.049118 |
GO:0051276 | chromosome organization | 2.8% (7/250) | 1.5 | 0.012577 | 0.049738 |
GO:0046907 | intracellular transport | 2.8% (7/250) | 1.49 | 0.013404 | 0.04991 |